Logo
  • Home
  • AI Agent
  • Annotations
  • Watchlists
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy

  • Get the full experience

    We save the real magic for signed-in users.

AbbVie Inc.(ABBV US)

$285.64+0.450.16%Ext:$291.92+6.282.20%(Market Closed · 00:00:05 UTC)

Overview

ProfileEntity Structure

Documents

SEC Filings
CategorizedChronologicalBy Owner
EDINET Filings

Financials & Metrics

FinancialsChartingShort InterestEmployees
Logo
ABBV US​

SEC Filings

Financials(56)

Expand
  • 10-QQ2ended 30 Jun 20263 Aug
  • 10-QQ1ended 31 Mar 20268 May
  • 10-KFY 2025ended 31 Dec 202520 Feb
  • 10-QQ3ended 30 Sept 20254 Nov 2025
  • 10-QQ2ended 30 Jun 20254 Aug 2025
  • 10-QQ1ended 31 Mar 20259 May 2025
  • 10-KFY 2024ended 31 Dec 202414 Feb 2025
  • 10-QQ3ended 30 Sept 20244 Nov 2024
  • 10-QQ2ended 30 Jun 20247 Aug 2024
  • 10-QQ1ended 31 Mar 20243 May 2024
  • 10-KFY 2023ended 31 Dec 202320 Feb 2024
  • 10-QQ3ended 30 Sept 20236 Nov 2023
  • 10-QQ2ended 30 Jun 20237 Aug 2023
  • 10-QQ1ended 31 Mar 20235 May 2023
  • 10-KFY 2022ended 31 Dec 202217 Feb 2023

Events(202)

Expand
  • 8-KDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers15 Oct
  • 8-KResults of Operations and Financial Condition5 Oct
  • 8-KRegulation FD Disclosure3 Sep
  • 8-KOther Events18 Aug
  • 8-KOther Events5 Aug
  • 8-KResults of Operations and Financial Condition31 Jul
  • 8-KResults of Operations and Financial Condition6 Jul
  • 8-KRegulation FD Disclosure22 Jun
  • 8-KSubmission of Matters to a Vote of Security Holders12 May
  • 8-KResults of Operations and Financial Condition29 Apr
  • 8-KResults of Operations and Financial Condition3 Apr
  • 8-KOther Events4 Mar
  • 8-KOther Events26 Feb
  • 8-KResults of Operations and Financial Condition4 Feb
  • 8-KResults of Operations and Financial Condition7 Jan

Insider Ownership(876)

Expand
  • 3Carethers John23 Oct
  • 4Quaggin Susan E2 Oct
  • 4RAPP EDWARD J2 Oct
  • 4Donoghoe Nicholas18 Aug
  • 4RAPP EDWARD J2 Jul
  • 4Quaggin Susan E2 Jul
  • 4FALK THOMAS J12 May
  • 4WADDELL FREDERICK H12 May
  • 4Roberts Rebecca B12 May
  • 4RAPP EDWARD J12 May
  • 4Quaggin Susan E12 May
  • 4MEYER MELODY B12 May
  • 4Hart Brett J12 May
  • 4FREYMAN THOMAS C12 May
  • 4Davis Jennifer L.12 May

Beneficial Ownership(43)

Expand
  • SC 13GAbbVie Inc.29 Apr
  • SC 13G/AAbbVie Inc.26 Mar
  • SC 13G/AAbbVie Inc.7 Jul 2025
  • SC 13GXilio Therapeutics, Inc.18 Feb 2025
  • SC 13G/AAbbVie Inc.13 Feb 2024
  • SC 13G/AAbbVie Inc.25 Jan 2024
  • SC 13G/AAbbVie Inc.16 Feb 2023
  • SC 13G/AAbbVie Inc.9 Feb 2023
  • SC 13G/AAbbVie Inc.9 Feb 2022
  • SC 13G/AAbbVie Inc.3 Feb 2022
  • SC 13G/AAbbVie Inc.16 Feb 2021
  • SC 13G/AAbbVie Inc.10 Feb 2021
  • SC 13G/AAbbVie Inc.29 Jan 2021
  • SC 13G/AAbbVie Inc.14 Feb 2020
  • SC 13G/AAbbVie Inc.12 Feb 2020

Other Ownership(59)

Expand
  • 144Donoghoe Nicholas14 Aug
  • 11-KAnnual report (employee stock purchase/savings/profit sharing plans)24 Jun
  • 144Alpern Robert J26 May
  • 144Purdue David Ryan6 Mar
  • 144Siatis Perry C2 Mar
  • 144Siatis Perry C25 Feb
  • 144GONZALEZ RICHARD A22 Aug 2025
  • 144GONZALEZ RICHARD A21 Aug 2025
  • 144SALEKI-GERHARDT AZITA12 Aug 2025
  • 144GONZALEZ RICHARD A8 Aug 2025
  • 144Donoghoe Nicholas5 Aug 2025
  • 11-KAnnual report (employee stock purchase/savings/profit sharing plans)13 Jun 2025
  • 144Stewart Jeffrey Ryan31 Mar 2025
  • 144Reents Scott T14 Mar 2025
  • 144Siatis Perry C3 Mar 2025

Proxies(65)

Expand
  • ARSAnnual report to security holders23 Mar
  • DEFA14ADefinitive additional materials23 Mar
  • DEF 14ADefinitive proxy statement23 Mar
  • PRE 14APreliminary proxy statement9 Mar
  • ARSAnnual report to security holders25 Mar 2025
  • DEFA14ADefinitive additional materials24 Mar 2025
  • DEF 14ADefinitive proxy statement24 Mar 2025
  • PRE 14APreliminary proxy statement10 Mar 2025
  • PX14A6GNotice of exempt solicitation2 Apr 2024
  • PX14A6GNotice of exempt solicitation26 Mar 2024
  • DEF 14ADefinitive proxy statement18 Mar 2024
  • DEFA14ADefinitive additional materials18 Mar 2024
  • ARSAnnual report to security holders18 Mar 2024
  • PRE 14APreliminary proxy statement4 Mar 2024
  • PX14A6GNotice of exempt solicitation4 May 2023

Registrations(127)

Expand
  • 424B5Prospectus filing (Rule 424(b)(5))6 Aug
  • FWPFree writing prospectus4 Aug
  • 424B5Prospectus filing (Rule 424(b)(5))4 Aug
  • 424B5Prospectus filing (Rule 424(b)(5))26 Feb
  • FWPFree writing prospectus26 Feb
  • FWPFree writing prospectus24 Feb
  • 424B5Prospectus filing (Rule 424(b)(5))24 Feb
  • 424B5Prospectus filing (Rule 424(b)(5))20 Feb 2025
  • FWPFree writing prospectus19 Feb 2025
  • 424B5Prospectus filing (Rule 424(b)(5))18 Feb 2025
  • S-3ASRAutomatic shelf registration statement (S-3)14 Feb 2025
  • S-8Registration statement (employee benefit plan)4 Nov 2024
  • S-8Registration statement (employee benefit plan)4 Nov 2024
  • S-8Registration statement (employee benefit plan)14 Aug 2024
  • 25-NSENotification of removal from listing3 Jun 2024

Filing Review Correspondence(19)

Expand
  • CORRESPFiling review correspondence4 Oct 2022
  • CORRESPFiling review correspondence19 Mar 2021
  • CORRESPFiling review correspondence15 Jan 2021
  • CORRESPFiling review correspondence14 Oct 2020
  • CORRESPFiling review correspondence14 Oct 2020
  • CORRESPFiling review correspondence10 May 2018
  • CORRESPFiling review correspondence21 Apr 2015
  • CORRESPFiling review correspondence1 Dec 2014
  • CORRESPFiling review correspondence17 Jan 2013
  • CORRESPFiling review correspondence26 Dec 2012
  • CORRESPFiling review correspondence19 Dec 2012
  • CORRESPFiling review correspondence10 Dec 2012
  • CORRESPFiling review correspondence7 Dec 2012
  • CORRESPFiling review correspondence30 Nov 2012
  • CORRESPFiling review correspondence16 Nov 2012

SEC Orders And Notices(5)

Expand
  • EFFECTNotice of effectiveness16 Oct 2020
  • CT ORDERConfidential treatment order14 Jun 2016
  • EFFECTNotice of effectiveness22 Apr 2015
  • EFFECTNotice of effectiveness8 Jul 2013
  • EFFECTNotice of effectiveness31 Dec 2012

Tender Offers And Going Private(23)

Expand
  • SC TO-I/ATender offer statement (issuer, amendment)4 Jun 2018
  • SC TO-I/ATender offer statement (issuer, amendment)30 May 2018
  • SC TO-I/ATender offer statement (issuer, amendment)30 May 2018
  • SC TO-I/ATender offer statement (issuer, amendment)18 May 2018
  • SC TO-I/ATender offer statement (issuer, amendment)14 May 2018
  • SC TO-I/ATender offer statement (issuer, amendment)10 May 2018
  • SC TO-I/ATender offer statement (issuer, amendment)9 May 2018
  • SC TO-I/ATender offer statement (issuer, amendment)3 May 2018
  • SC TO-I/ATender offer statement (issuer, amendment)1 May 2018
  • SC TO-ITender offer statement (issuer)1 May 2018
  • SC TO-CTender offer statement (communication)26 Apr 2018
  • SC TO-C8-K26 Apr 2018
  • SC TO-T/ATender offer statement (third-party, amendment)26 May 2015
  • SC TO-T/ATender offer statement (third-party, amendment)22 May 2015
  • SC TO-T/ATender offer statement (third-party, amendment)21 May 2015

Exempt Offerings(1)

Expand
  • D06b9 May 2016

Other(22)

Expand
  • SDSD1 Jun
  • SDSD30 May 2025
  • SDSD31 May 2024
  • SDSD31 May 2023
  • SDSD31 May 2022
  • SDSD1 Jun 2021
  • CERTCERT20 Nov 2020
  • SDSD1 Jun 2020
  • CERTCERT26 Sep 2019
  • SDSD31 May 2019
  • SDSD31 May 2018
  • SDSD31 May 2017
  • NO ACTAUTO-GENERATED PAPER DOCUMENT16 Mar 2017
  • NO ACTAUTO-GENERATED PAPER DOCUMENT7 Mar 2017
  • NO ACTAUTO-GENERATED PAPER DOCUMENT1 Mar 2017